TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biovica International AB
Closing information (x1000 EUR)
| Closing information | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Turnover |
198
|
205 | |
| Financial expenses |
8
|
6 | |
| Earnings before taxes |
-5,818
|
-3,880 | |
| EBITDA |
-5,204
|
-3,353 | |
| Total assets |
14,706
|
18,976 | |
| Current assets |
9,205
|
14,506 | |
| Current liabilities |
1,561
|
847 | |
| Equity capital |
12,035
|
17,992 | |
| - share capital |
184
|
155 | |
| Employees (average) |
31
|
25
|
20 |
Financial ratios
| Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Solvency |
81.8%
|
94.8% | |
| Turnover per employee |
8
|
10 | |
| Profit as a percentage of turnover |
-2938.4%
|
-1892.7% | |
| Return on assets (ROA) |
-39.5%
|
-20.4% | |
| Current ratio |
589.7%
|
1712.6% | |
| Return on equity (ROE) |
-48.3%
|
-21.6% | |
| Change turnover |
-3
|
40 | |
| Change turnover % |
65%
|
-2%
|
24% |
| Chg. No. of employees |
6
|
5
|
3 |
| Chg. No. of employees % |
24%
|
25%
|
18% |
Total value of public sale
| Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.